October 31, 2012

Genzyme Announces Publication of LEMTRADATM (alemtuzumab) Pivotal Studies in The Lancet

-Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS I and CARE-MS II publications-

 

Genzyme Announces Publication of LEMTRADATM (alemtuzumab) Pivotal Studies in The Lancet
-Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS I and CARE-MS II publications-

Content